1–2 of 2 results for RO-104
RO-104, a Novel Trispecific Antibody, Significantly Reduces Lesion Area and Vascular Leakage in a Laser-Induced Nonhuman Primate CNV Model
Harit K. Bhatt, MD, MBA, FASRS, FACS
Annual Meeting Talks
2025
Preclinical Analysis of a Novel Trispecific Antibody, RO-104, for Use in Retinal Neovascular Disease
Subhransu K. Ray, MD, PhD
2024